Conditions That Simulate the Environment of Atopic Dermatitis Enhance Susceptibility of Human Keratinocytes to Vaccinia Virus
Open Access
Abstract
Individuals with underlying chronic skin conditions, notably atopic dermatitis (AD), are disproportionately affected by infections from members of the herpesviridae, papovaviridae, and poxviridae families. Many patients with AD experience recurrent, widespread cutaneous viral infections that can lead to viremia, serious organ complications, and even death. Little is known about how the type 2 inflammatory environment observed in the skin of AD patients impacts the susceptibility of epidermal cells (keratinocytes) to viral pathogens. Herein, we studied the susceptibility of keratinocytes to the prototypical poxvirus, vaccinia virus (VV)—the causative agent of eczema vaccinatum—under conditions that simulate the epidermal environment observed in AD. Treatment of keratinocytes with type 2 cytokines (IL-4 and -13) to simulate the inflammatory environment or a tight junction disrupting peptide to mirror the barrier disruption observed in AD patients, resulted in a differentiation-dependent increase in susceptibility to VV. Furthermore, pan JAK inhibition was able to diminish the VV susceptibility occurring in keratinocytes exposed to type 2 cytokines. We propose that in AD, the increased viral susceptibility of keratinocytes leads to enhanced virus production in the skin, which contributes to the rampant dissemination and pathology seen within patients.Keywords
Funding Information
- National Institute of Allergy and Infectious Diseases (AI146800, AI067691, AI18689, AI007285, U01AI152011, 1U19AI117673, AI126005)
This publication has 53 references indexed in Scilit:
- Vaccinia viruses: vaccines against smallpox and vectors against infectious diseases and tumorsExpert Review of Vaccines, 2011
- Reductions in claudin-1 may enhance susceptibility to herpes simplex virus 1 infections in atopic dermatitisJournal of Allergy and Clinical Immunology, 2011
- Development of Vaccinia reporter viruses for rapid, high content analysis of viral function at all stages of gene expressionAntiviral Research, 2011
- Human atopic dermatitis complicated by eczema herpeticum is associated with abnormalities in IFN-γ responseJournal of Allergy and Clinical Immunology, 2011
- Nonlesional atopic dermatitis skin is characterized by broad terminal differentiation defects and variable immune abnormalitiesJournal of Allergy and Clinical Immunology, 2011
- Tight junction defects in patients with atopic dermatitisJournal of Allergy and Clinical Immunology, 2011
- Stunned Silence: Gene Expression Programs in Human Cells Infected with Monkeypox or Vaccinia VirusPLOS ONE, 2011
- Vaccinia virus inoculation in sites of allergic skin inflammation elicits a vigorous cutaneous IL-17 responseProceedings of the National Academy of Sciences, 2009
- Phenotype of atopic dermatitis subjects with a history of eczema herpeticumJournal of Allergy and Clinical Immunology, 2009
- Inhibition of NK cell activity by IL-17 allows vaccinia virus to induce severe skin lesions in a mouse model of eczema vaccinatumJournal of Experimental Medicine, 2009